Status and phase
Conditions
Treatments
About
Three way crossover study to assess the bioavailability of 656 under fed and fasted conditions.
Full description
This study will assess in healthy male subjects a solid oral dose formulation of CTP-656 under fasted and fed conditions.
Primary:
• To characterize the relative bioavailability and pharmacokinetic profile of a single 150 mg solid oral dose of CTP-656 in healthy volunteers under fasted, fed low-fat and fed moderate-fat conditions.
Secondary:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
15 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal